Richard Kermit Miller, Ph.D.

Dr. Miller is Director of MotherToBaby UR Medicine (formerly known as the Perinatal Environmental and Drug Consultation Service) a Teratogen Information Service serving New Jersey, New York and Indiana) from the Department of Obstetrics and Gynecology at the University of Rochester Medical Center. This service was begun in 1987 and provides expertise concerning exposures during pregnancy or before pregnancy to environmental, occupational and therapeutic exposures to the women and/or family.

In 2015, Dr. Miller has co-edited the 3rd edition of "Drugs During Pregnancy and Lactation - Treatment Options and Risk Assessment".

Since 2007, Dr. Miller has been Co-Director of the New York State Center of Excellence in Children's Environmental Health for the 15 county Finger Lakes Region of New York State.

Dr. Miller provides these services to health care providers and families by telephone or by appointment. Please call 585 275 3638.

He has been Scientific Director of the NIH sponsored Women's Reproductive Health Research Scholars Program for training Obstetrician/Gynecologists as Clinical Scientists.

Dr. Miller is a member of the Scientific Board of TERIS as well as Dysmorphologist and Scientific Board Member for the US Ribavirin Pregnancy Registry, Belimumab Pregnancy Registry and MotHER Pregnancy Registry. He is also Co-Chair of the Perinatal LifeStages Committee, Co-Chair of the BioSpecimen Utilization Committee and Member of the Steering Committee for the NIH ECHO (Environmental Influences on Children's Health Outcome) Study of 50,000 children.

Professional Background

Dr. Miller received his undergraduate in Biology and graduate training in Pharmacology/Toxicology /Teratology at Dartmouth College and Dartmouth Medical School with Prs WO Berndt, G Mudge, V Ferm and W Layton . He also did post graduate training at Jefferson Medical College with Prs RL Brent and T Koszalka in Developmental Biology /Teratology. In 1974, he joined the Departments of Obs/Gyn at the University of Rochester under Pr HA Thiede and of Pharm/Toxicol under Pr L Lasagna as an Assistant Professor. He is currently Professor of Obstetrics and Gynecology, of Environmental Medicine (Toxicology) and of Pathology and Clinical Laboratory Medicine.

During this time, he has been involved with the leadership of the NIEHS Environmental Health Sciences Ctr, as well as Associate Chair for Research in Obstetrics and Gynecology. In 1987, he began the Perinatal Environmental and Drug Consultation Service (PEDECS) (now known as MotherToBaby UR Medicine) in Obs/Gyn and is its Director. This service provides advice concerning exposures during pregnancy or before pregnancy to environmental, occupational and therapeutic exposures to the women and/or famiies. He also is co-Director of the New York State Ctr of Excellence in Children's Environmental Health at the U of Rochester (Finger Lakes Children's Environmental Health Center.

Dr. Miller is Past President of the Teratology Society and has been active with Natl and Intl concerns involving vitamins and herbals as well as environmental exposures during pregnancy.

He is actively involved with OTIS, Organization of Teratology Information Specialists, with their Committees on Occupational Exposures and on Research. He is currently Chair of the International Research Consortium for OTIS and ENTIS, and recently was the Chair of the Research Funding Committee for the Society of Toxicology. He has been Scientific Director of the NIH sponsored Women's Reproductive Health Research Scholars Program for training Obs/ Gyns as Clinical Scientists at the U of Rochester from 1999-2010.

Dr. Miller has edited the 3rd ed. of "Drugs During Pregnancy and Lactation - Treatment Options and Risk Assessment".

Dr. Miller is a member of the Scientific Board of TERIS as well as a Dysmorphologist and Scientific Board Member for the US Ribavirin Pregnancy Registry and the Genentech MoTHER Pregnancy Registry.

He has been involved with a number of research programs with the National Toxicology Program (Scientific Board), the FDA, NIH, Merck, Roche, Centecor, Eastman Kodak, Johnson and Johnson and other partners. He has trained more than 25 fellows and graduate students, who are providing leadership in Academia, Government and Industry.

His funding does and has come from NICHHD, NIAID, NIAAA, NCI, NIEHS, FDA, NCS, US Israel Binational Fdn, Goode Fdn and industry partners. He was the recipient of the Bock Prize for Developmental Biology and Child Health in 2011 and received the Distinguished Service Award from the Teratology Society in 2013.

For 2014-16, he has spoken or is speaking at

• Chair and Speaker: Teratology Society Symposium – Advances in Placental Research June 28, 2016
Title: Predicting Fetal and Newborn Health: The Role of the Placenta

• Education Lecturer, Teratology Society Education Course, Montreal, Canada 2015.
Title: How to Evaluate Workplace, Environmental and Home Exposure: Their Risks during Pregnancy

• Alumni Grand Rounds Speaker, Obstetrics/Gynecology Grand Rounds, University of Rochester School of Medicine and Dentistry, Rochester, New York 2014.

• Symposium Speaker, European Network of Teratology Information Services (ENTIS) and the Organization of Teratology Information Services (OTIS) Joint Meeting II - Toronto, Canada, 2014.

• Plenary Speaker, International Federation of Placenta Association 2014 Meeting, Paris, France, 2014.

• Symposium Speaker, Teratology Society, Bellevue, Washington, 2014

Research